World Marine Biotechnology Market

TENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability And Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions And Scope Of Study I-3
By Product Segment I-3
Biomaterials I-3
Bioactive Substances I-3
Others I-3
By End-Use Application I-3
Industrial Products I-3
Health Care/Biotechnology I-3
Consumer Products I-4
Public Services And Infrastructure I-4
Others I-4

II. EXECUTIVE SUMMARY

1. Industry Dynamics II-1
Market Scorecard II-1
Trends and Issues II-1
Medical and Industrial Sectors Garner Research Dollars II-1
Lack of R&D Investment in the Marine Biotech Industry II-2
Preserving Marine Ecology: A Prime Concern II-2

2. Marine Biotechnology - An Overview II-3
A Curtain Raiser II-3
Why are Microorganisms Crucial? II-3
Brief History II-4
Definition II-4
Sources of Marine Biotech Products II-5
Key Marine Sources and Products II-5
Select Marine-Derived Products II-5
Flora and Fauna II-6
Protista II-6
Bacteria II-6
Fungi II-6
Types of Marine Biotech Products II-6
Marine Biomaterials II-7
Marine Adhesives II-7
Marine Bioactive Substances II-7
Select Biological Materials and Chemicals Extracted from
Marine Organisms II-8
Select Companies Involved in Supplying Reagents or
Nutritional Products from Marine Organisms II-9
Enzymes II-9
Haloperoxidase Enzymes II-9
Thermostable DNA-Modifying Enzymes II-10
Other Marine Products and Processes II-10
Marine Biomass II-10
Marine Bio-Process II-10
Certain Significant Bio-Processes and their Application II-10
End-Use Analysis II-10
Definition II-10
Overview II-11
Application Areas II-12
Foods II-12
Nutraceuticals II-12
Medicine II-12
Cosmetics II-12
Research Tools II-13
Processing Technologies II-13
New Energy Sources II-13
Agriculture II-13
Industrial II-13
Food Safety II-14
Environmental Management II-14
Bioremediation II-14
Marine Biosurfactants II-14
Select Biosurfactants Produced from Marine Microorganisms II-15
Aquaculture and Marine Biotechnology II-15
Select Companies Carrying Out Genetic Enhancement or
Aquaculture Breeding Programs II-16
Industrial Applications II-16
Healthcare II-16
Select Therapeutic Compounds in the Pipeline II-17
Select Marine Diterpenes and Their Biological Activity II-17
Select Players Involved in Biosensor/Diagnostic Activity II-17
Select Marine-Based Drugs II-17
Cytosar-U II-17
Prialt II-18
Yondelis II-18
Bryostatin II-18
Didemnin B II-18
Dehydrodidemnin B II-18
Pseudopterosins II-18
Bio-Prospecting II-18
Select Companies Involved in Bioprospecting and
Bioscreening for Novel Marine-Based Compounds II-19
Consumer Products II-19
Select Macroalgal Materials and Their Application in
Cosmetic Industry II-19
Public Services and Infrastructure II-20
Others II-20
Agriculture II-20
Mining II-20
An Insight into Select Marine-Origin Products II-20
Agar II-20
Major Seaweeds Used for Extracting Agar and Agarose II-20
Alginate II-21
Astaxanthin II-21
Select Producers of Natural and Synthetic Astaxanthin II-22
Carrageenan II-22
Chitin and Chitosan II-23
Chitin II-23
End-use Applications II-23
Chitosan II-24
Select Industrial Applications of Chitosan II-24
Collagen II-25
Salmon Calcitonin II-25
Research and Development Activity II-25
Medical II-25
Research on Natural Products II-25
Tackling Biotoxins II-26
Controlling Oil Spill Damage II-26
Preventing Biofouling II-26
Antifouling Coatings II-26
Coral Reefs Offer Abundant Opportunities II-26

3. Regional Market Overview II-28
United States II-28
Market Outlook II-28
Overview II-28
Aquaculture Biotechnology II-28
Rest of World II-28
Market Outlook II-28
Australia II-29
Canada II-29
China II-29
Europe II-30
United Kingdom II-30
Norway II-31
Overview II-31
Market Participants II-31
Industrial Applications II-31
Pharmaceuticals II-31
Latin America II-32
India II-32
Marine Environment Offers Abundant Opportunities for R&D
Initiatives II-32
Market Participants II-32
Government Initiatives II-33
New Zealand II-33

4. Recent Industry Activity II-34
Aker BioMarine Merges with Natural ASA to Form Aker BioMarine II-34
Aker BioMarine Joins Hands with Pronova Biocare II-34
ABL Biotech to Establish New R&D Facility II-34
Aquapharm Strikes an Agreement with DowpharmaSM II-34
MMRC and Nereus Pharmaceuticals to Initiate Clinical Trials
for NPI-0052 II-34
CP Kelco Acquires Gold Millet II-34
Oman�s Attempt To Excel in Marine Research II-35
Marical Inks an Agreement with ACD II-35
PharmaMar Conducts Clinical Testing of Zalypsis � Anti-tumor
Agent II-35
Indore Biotech Inputs to Introduce Fungi-Based Biopesticides II-35
CP Kelco Merges with Noviant II-35
Marine Institute, Biotrove, and NUI�S Cooperative Research on
Atlantic Salmon II-36
Jinghua Marine Biological Merges with Work Recovery Inc II-36
Albany Molecular Research and Alcon Research in Partnership II-36
Maryland-Israel Marine Biotechnology Research Program Gains
Extension II-36
India to Set Up New National Institutions II-36
European Centre for Marine Biotechnology Inaugurated II-37
Diversa Collaborates with OSU II-37
PharmaMar Commences Phase I Clinical Trials of PM02734 II-37
USFDA Confers Orphan Drug Status to PharmaMar�s Ovarian
Cancer Drug, YONDELIS� II-37
PharmaMar Undertakes Phase II Clinical Trials of Aplidin �
for Bladder and Prostate Cancers II-37
CorMatrix and Cook Biotech Enter into Research Agreement II-37
Elan Corp Receives European Approval for PRIALT� (Ziconotide) II-38

5. Focus on Select Players II-39
Aker BioMarine ASA (Norway) II-39
CP Kelco US, Inc. (USA) II-39
Cyanotech Corp. (USA) II-39
Elan Corp (Ireland) II-39
FMC Corp. (USA) II-40
FMC Biopolymers AS (Norway) II-40
GlycoMar Ltd. (UK) II-40
Integrin Advanced Biosystems (UK) II-40
International Specialty Products Inc (USA) II-40
Lonza Group Ltd (Switzerland) II-41
MariCal (USA) II-41
Marinova (Australia) II-41
Martek Biosciences Corp. (USA) II-42
Mera Pharmaceuticals Inc (USA) II-42
New England Biolabs Inc (USA) II-42
PharmaMar S.A (Spain) II-42
PML Applications Ltd. (UK) II-42
Primex Ltd (Iceland) II-43
Prolume Ltd (USA) II-43
Sea Run Holdings Inc (USA) II-43
Tequesta Marine Biosciences (USA) II-44

6. Global Market Perspective II-45
Table 1: World Recent Past, Current & Future Analysis for
Marine Biotechnology by Geographic Region- United States and
Rest of World Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2003 through 2012 (includes
corresponding Graph/Chart) II-45

Table 2: World 10-Year Perspective for Marine Biotechnology by
Geographic Region- Percentage Breakdown of Dollar Sales for
United States and Rest of World Markets for Years 2003, 2007 &
2012 II-45

Table 3: World Recent Past, Current & Future Analysis for
Marine Biotechnology by Product Segment- Marine Biomaterials,
Marine Bioactive Substances, and Others Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2003
through 2012 (includes corresponding Graph/Chart) II-46

Table 4: World 10-Year Perspective for Marine Biotechnology by
Product Segment- Percentage Breakdown of Dollar Sales for
Marine Biomaterials, Marine Bioactive Substances and Other
Markets for Years 2003, 2007 & 2012 (includes corresponding
Graph/Chart) II-46

Table 5: World Recent Past, Current & Future Analysis for
Marine Biotechnology by End-use Application-Industrial
Products, Health Care/Biotechnology, Consumer Products, Public
Services and Infrastructure and Other Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2003
through 2012 (includes corresponding Graph/Chart) II-47

Table 6: World 10-Year Perspective for Marine Biotechnology by
End-Use Application- Percentage Breakdown of Dollar Sales for
Industrial Products, Health Care/ Biotechnology, Consumer
Products, Public Services and Infrastructure and Other Markets
for Years 2003, 2007 & 2012 (includes corresponding
Graph/Chart) II-48

III. COMPETITIVE LANDSCAPE